参考文献/References:
[1] Gassmann R,Carvalho A,Henzing AJ,et al.Borealin:A novel chromosomal passenger required for stability of the bipolar mitotic spindle[J].J Cell Biol,2004,166(2):179-191.
[2] Sampath SC,Ohi R,Leismann O,et al.The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly[J].Cell,2004,118(2):187-202.
[3] Lens SM,Vader G,Medema RH.The case for survivin as mitotic regulator[J].Curr Opin Cell Biol,2006,18(6):616-622.
[4] Jeyaprakash AA,Klein UR,Lindner D,et al.Structure of a survivin-borealin-INCENP core complex reveals how chromosomal passengers travel together[J].Cell,2007,131(2):271-285.
[5] Bonner MK,Haase J,Saunders H,et al.The Borealin dimerization domain interacts with Sgo1 to drive aurora B-mediated spindle assembly[J].Mol Biol Cell,2020,31(20):2207-2218.
[6] Vader G,Kauw JJ,Medema RH,et al.Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody[J].EMBO Rep,2006,7(1):85-92.
[7] Trivedi P,Palomba F,Niedzialkowska E,et al.The inner centromere is a biomolecular condensate scaffolded by the chromosomal passenger complex[J].Nat Cell Biol,2019,21(9):1127-1137.
[8] Abad MA,Ruppert JG,Buzuk L,et al.Borealin-nucleosome interaction secures chromosome association of the chromosomal passenger comple[J].J Cell Biol,2019,218(12):3912-3925.
[9] Trivedi P,Zaytsev AV,Godzi M,et al.The binding of Borealin to microtubules underlies a tension independent kinetochore-microtubule error correction pathway[J].Nat Commun,2019,10(1):682.
[10] Liu J,Cheng F,Deng LW.MLL5 maintains genomic integrity by regulating the stability of the chromosomal passenger complex through a functional interaction with Borealin[J].J Cell Sci,2012,125(19):4676-4685.
[11] Liu X,Song Z,Huo Y,et al.Chromatin protein HP1 interacts with the mitotic regulator borealin protein and specifies the centromere localization of the chromosomal passenger complex[J].J Biol Chem,2014,289(30):20638-20649.
[12] Wumaier R,Aili A,Saiyin H,et al.The correct localization of borealin in midbody during cytokinesis depends on IQGAP1[J].Biomed Res Int,2020,2020:6231697.
[13] Dai C,Miao CX,Xu XM,et al.Transcriptional activation of human CDCA8 gene regulated by transcription factor NF-Y in embryonic stem cells and cancer cells[J].J Biol Chem,2015,290(37):22423-22434.
[14] Pike T,Brownlow N,Kjaer S,et al.PKCε switches aurora B specificity to exit the abscission checkpoint[J].Nat Commun,2016,7:13853.
[15] Comisso E,Scarola M,Rosso M,et al.OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness[J].Oncogene,2017,36(30):4253-4266.
[16] Bray F,Ferlay J,Soerjomataram I,et al.Erratum:Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2020,70(4):313.
[17] Li Z,Qi F,Li F.Establishment of a gene signature to predict prognosis for patients with lung adenocarcinoma [J].Int J Mol Sci,2020,21(22):1692-1698.
[18] Hayama S,Daigo Y,Yamabuki T,et al.Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis[J].Cancer Res,2007,67(9):4113-4122.
[19] Zeng H,Ji J,Song X,et al.Stemness related genes revealed by network analysis associated with tumor immune microenvironment and the clinical outcome in lung adenocarcinoma[J].Front Genet,2020,11:549213.
[20] 马丹丹,刘 坤,齐晓伟.2018年全球癌症统计:乳腺癌发病和死亡人数统计[J].中华乳腺病杂志:电子版,2018,12(6):375.
[21] Bu Y,Shi L,Yu D,et al.CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells [J].Gene,2019,703:1-6.
[22] Jiao DC,Lu ZD,Qiao JH,et al.Expression of CDCA8 correlates closely with FOXM1 in breast cancer:Public microarray data analysis and immunohistochemical study[J].Neoplasma,2015,62(3):464-469.
[23] Morse MA,Sun W,Kim R,et al.The role of angiogenesis in hepatocellular carcinoma[J].Clin Cancer Res,2019,25(3):912-920.
[24] Shuai Y,Fan E,Zhong Q,et al.CDCA8 as an independent predictor for a poor prognosis in liver cancer [J].Cancer Cell Int,2021,21(1):159.
[25] Li L,Li D,Tian F,et al.Hepatic loss of borealin impairs postnatal liver development,regeneration,and hepatocarcinogenesis [J].J Biol Chem,2016,291(40):21137-21147.
[26] Jeon T,Ko MJ,Seo YR,et al.Silencing CDCA8 suppresses hepatocellular carcinoma growth and stemness via restoration of ATF3 tumor suppressor and inactivation of AKT/β-Catenin signaling[J].Cancers(Basel),2021,13(5):341-347.
[27] Siegel RL,Miller KD,Jemal A.Cancer statistics,2019 [J].A Cancer Journal for Clinicians,2019,69(1):241-246.
[28] Gao X,Wen X,He H,et al.Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells[J].Peer J,2020,8:9078.
[29] Pan S,Zhan Y,Chen X,et al.Identification of biomarkers for controlling cancer stem cell characteristics in bladder cancer by network analysis of transcriptome data stemness indices[J].Front Oncol,2019,9:613.
[30] Li B,Liu B,Zhang X,et al.KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8[J].J Cell Physiol,2020,235(5):4227-4238.
[31] Gao CT,Ren J,Yu J,et al.KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target[J].Ann Transl Med,2020,8(21):1394.
[32] Li Q,Liang J,Chen B.Identification of CDCA8,DSN1 and BIRC5 in regulating cell cycle and apoptosis in osteosarcoma using bioinformatics and cell biology[J].Technol Cancer Res Treat,2020,19:1533.
[33] Ci C,Tang B,Lyu D,et al.Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis[J].Int J Mol Med,2019,43(1):404-412.
[34] Wang Y,Zhao Z,Bao X,et al.Borealin/Dasra B is overexpressed in colorectal cancers and contributes to proliferation of cancer cells[J].Med Oncol,2014,31(11):248.
[35] Wang X,Wang H,Xu J,et al.Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma[J].Cell Death Dis,2021,12(2):146.
[36] Xu N,Chen SH,Lin TT,et al.Development and validation of hub genes for lymph node metastasis in patients with prostate cancer [J].J Cell Mol Med,2020,24(8):4402-4414.
[37] Lowenberg B,Muus P,Ossenkoppele G,et al.Phase 1/2 study to assess the safety,efficacy,and pharmacokinetics of barasertib(AZD1152)in patients with advanced acute myeloid leukemia[J].Blood,2011,118(23):6030-6036.
[38] Yue L,Li L,Li D,et al.High-throughput screening for survivin and borealin interaction inhibitors in hepatocellular carcinoma[J].Biochem Biophys Res Commun,2017,484(3):642-647.
[39] Yu D,Shi L,Bu Y,et al.Cell division cycle associated 8 is a key regulator of tamoxifen resistance in breast cancer [J].J Breast Cancer,2019,22(2):237-247.
[40] Qi G,Zhang C,Ma H,et al.CDCA8,targeted by MYBL2,promotes malignant progression and olaparib insensitivity in ovarian cancer[J].American Journal of Cancer Research,2021,11(2):389-415.
相似文献/References:
[1]文 栋,王西宾△.99Tcm-MDP全身骨扫描及局部单光子发射计算机断层成像在骨转移性肿瘤诊断中的临床应用*[J].陕西医学杂志,2020,49(7):808.[doi:DOI:10.3969/j.issn.10007377.2020.07.010]
WEN Dong,WANG Xibin..Diagnostic value of 99Tcm-MDP whole body bone scan and local SPECT in bone metastatic tumors[J].,2020,49(8):808.[doi:DOI:10.3969/j.issn.10007377.2020.07.010]
[2]樊 盼,陆建荣,姚俊涛△.颗粒蛋白前体在肿瘤发生和发展中的作用研究进展[J].陕西医学杂志,2020,49(7):910.[doi:DOI:10.3969/j.issn.10007377.2020.07.039]
FAN Pan,LU Jianrong,YAO Juntao..Research progress on the role of progranulin in tumors[J].,2020,49(8):910.[doi:DOI:10.3969/j.issn.10007377.2020.07.039]
[3]杨 旭,张致英,康龙丽,等.环状RNA与代谢性疾病研究进展[J].陕西医学杂志,2021,50(1):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
YANG Xu,ZHANG Zhiying,KANG Longli,et al.Advances in circular RNA and metabolic diseases[J].,2021,50(8):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
[4]陈正浤,李媛媛,雷光焰,等.Ⅰ型分裂蛋白转导素样增强子在肿瘤中的作用研究进展[J].陕西医学杂志,2021,50(4):511.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.034]
[5]黄 静,陈佳茹,喻 莹,等.抑癌基因BLU在肿瘤中的作用及分子机制研究进展[J].陕西医学杂志,2021,50(11):1462.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.035]
HUANG Jing,CHEN Jiaru,YU Ying,et al.Role and molecular mechanism of tumor suppressor gene BLU in tumors[J].,2021,50(8):1462.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.035]
[6]陈 丹,王文静,王庆雅,等.生物发光成像技术在肿瘤细胞活体可视化研究中的应用研究进展[J].陕西医学杂志,2022,51(1):111.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.028]
CHEN Dan,WANG Wenjing,WANG Qingya,et al.Application of bioluminescence imaging technology in visualization of cancer cells in vivo[J].,2022,51(8):111.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.028]
[7]王 剑,魏媛媛,朱利双,等.长链非编码RNA RAB11B-AS1在胶质瘤中的表达及预后价值研究[J].陕西医学杂志,2023,52(4):399.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.008]
WANG Jian,WEI Yuanyuan,ZHU Lishuang,et al.Expression and prognostic value of lncRNA RAB11B-AS1 in glioma[J].,2023,52(8):399.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.008]
[8]黄丽银,斯 韬,梁 婷,等.丙酮酸脱氢酶激酶4在肝细胞癌中的作用研究进展[J].陕西医学杂志,2023,52(7):934.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.036]
HUANG Liyin,SI Tao,LIANG Ting,et al.Research progress on role of pyruvate dehydrogenase kinase 4 in hepatocellular carcinoma[J].,2023,52(8):934.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.036]
[9]李 欣,潘宇飞,万旭英.三氧化二砷在肿瘤治疗中临床应用及相关分子机制研究进展[J].陕西医学杂志,2024,(5):703.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.029]
LI Xin,PAN Yufei,WAN Xuying.Research progress on clinical application and related molecular mechanism of arsenic trioxide in tumor treatment[J].,2024,(8):703.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.029]